title: Cervical pregnancy: case reports and a current literature review.
abstract: The increasing number of reports of successful conservative treatment of cervical pregnancy, such as using the folinic acid antagonist methotrexate, constitutes a breakthrough in the management of this unusual but potentially life-threatening complication of pregnancy. We are reporting two cases of cervical pregnancy, both diagnosed in the first trimester of pregnancy. The first one was successfully treated by transvaginal ultrasound-guided administration of 2 mEq KCI intraamniotically in order to stop the fetal heart activity, followed by administration of 84 mg of methotrexate intraaminiotically (1 mg/kg); whereas in the second case, we encountered a technical failure of the above method. Both patients expressed desire to maintain their reproductive capability. These two cases gave us the opportunity to review the recent literature on cervical pregnancy.
authors.affiliation: Department of Obstetrics and Gynecology University of Illinois, Chicago 60612.
authors.forename: I
authors.initials: I
authors.lastname: Marcovici
authors.forename: B A
authors.initials: BA
authors.lastname: Rosenzweig
authors.forename: A I
authors.initials: AI
authors.lastname: Brill
authors.forename: M
authors.initials: M
authors.lastname: Khan
authors.forename: A
authors.initials: A
authors.lastname: Scommegna
mesh_terms: D000328:Adult; D000650:Amnion; D002584:Cervix Uteri; D005260:Female; D006801:Humans; D007267:Injections; D008727:Methotrexate / Q000008:administration & dosage*; D011189:Potassium Chloride / Q000008:administration & dosage*; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000000981:diagnostic imaging / Q000628:therapy*; D014463:Ultrasonography
chemical_list: D011189:Potassium Chloride; D008727:Methotrexate